2024-11-25 05:33:28
Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting
Corporate/ 2023-07-23
Ascentage Pharma Announces Positive Data...

SUZHOU,China,and ROCKVILLE,MD,Dec. 8,2020-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in de...

Willis Towers Watson's Survey Expects Medical Costs in Indonesia to Increase up to 12% in 2021
Corporate/ 2023-07-23
Willis Towers Watson's Survey Expec...

JAKARTA,Indonesia,Dec. 8,2020-- Willis Towers Watson (NASDAQ: WLTW),a leading global advisory,broking and solutions company,announced it exp...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release